AI
Sunday, October 03, 2004 8:48:05 AM
Dew,
Nearly every binary bio event can have third more neutral possibilities. Why do you think bio's data dredge?
That's the risk in playing straddles.
Depending of course on where agix is trading at the time, I'd argue your #2,3,4,5 and 6 scenario's all would smash agix stock.
Even #2, assuming a need for a 2nd and larger pivotal trial and multi year delay would be considered a negative outcome.
BTW: I think Topol's comments were a little over the top and not entirely fair. They had fda permission to take an interim look and took a statistical hit for it. And what do the Dr's care what agix share price did? I don't think that's their place. Full data set in Dec, we'll see.
Nearly every binary bio event can have third more neutral possibilities. Why do you think bio's data dredge?
That's the risk in playing straddles. Depending of course on where agix is trading at the time, I'd argue your #2,3,4,5 and 6 scenario's all would smash agix stock.
Even #2, assuming a need for a 2nd and larger pivotal trial and multi year delay would be considered a negative outcome.
BTW: I think Topol's comments were a little over the top and not entirely fair. They had fda permission to take an interim look and took a statistical hit for it. And what do the Dr's care what agix share price did? I don't think that's their place. Full data set in Dec, we'll see.
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
